48 results on '"Wiid I"'
Search Results
2. Virulence, biochemistry, morphology and host-interacting properties of detergent-free cultured mycobacteria: An update
- Author
-
Leisching, G., Pietersen, R.-D., Wiid, I., and Baker, B.
- Published
- 2016
- Full Text
- View/download PDF
3. The functional interplay of low molecular weight thiols in Mycobacterium tuberculosis
- Author
-
Sao Emani, C., Williams, M. J., Wiid, I. J., and Baker, B.
- Published
- 2018
- Full Text
- View/download PDF
4. DRUG SUSCEPTIBILITY TESTING OF MYCOBACTERIUM TUBERCULOSIS TO ISONIAZID AND FLUOROQUINOLONE ENTRAPPED 1,2 DIPALMITOYL-L-α-PHOSPHATIDYLCHOLINE LIPOSOMES: 736
- Author
-
Van Rensburg, L., Van Zyl, J., Smith, J., and Wiid, I.
- Published
- 2014
5. IN VITRO ACTIVITY OF A NEW SERIES OF SYNTHETIC COMPOUNDS FOR ANTITUBERCULOSIS DRUG DEVELOPMENT: 410
- Author
-
Ngwane, A., Styger, G., Pietersen, R., Kendrekar, P., Wiesner, L., Baker, B., van Helden, P., and Wiid, I.
- Published
- 2014
6. Boza, a natural source of probiotic lactic acid bacteria
- Author
-
Todorov, S. D., Botes, M., Guigas, C., Schillinger, U., Wiid, I., Wachsman, M. B., Holzapfel, W. H., and Dicks, L. M.T.
- Published
- 2008
7. Total Antioxidant Levels are Low During Active TB and Rise with Anti-tuberculosis Therapy
- Author
-
Wiid, I., Seaman, T., Hoal, E. G., Benade, A. J.S., and Van Helden, Paul D.
- Published
- 2004
8. Generation and characterization of thiol-deficient Mycobacterium tuberculosis mutants
- Author
-
Sao Emani, C., primary, Williams, M. J., additional, Van Helden, P. D., additional, Taylor, M. J. C., additional, Carolis, C., additional, Wiid, I. J., additional, and Baker, B., additional
- Published
- 2018
- Full Text
- View/download PDF
9. Compounds with Potential Activity against Mycobacterium tuberculosis
- Author
-
Sao Emani, C., primary, Williams, M. J., additional, Wiid, I. J., additional, Baker, B., additional, and Carolis, C., additional
- Published
- 2018
- Full Text
- View/download PDF
10. Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform
- Author
-
Theron, A., primary, Roth, R. L., additional, Hoppe, H., additional, Parkinson, C., additional, van der Westhuyzen, C. W., additional, Stoychev, S., additional, Wiid, I., additional, Pietersen, R. D., additional, Baker, B., additional, and Kenyon, C. P., additional
- Published
- 2017
- Full Text
- View/download PDF
11. Sulfamethoxazole enhances the antimycobacterial activity of rifampicin
- Author
-
Macingwana, L., primary, Baker, B., additional, Ngwane, A. H., additional, Harper, C., additional, Cotton, M. F., additional, Hesseling, A., additional, Diacon, A. H., additional, van Helden, P., additional, and Wiid, I., additional
- Published
- 2012
- Full Text
- View/download PDF
12. The antimicrobial activity of copper and copper alloys against nosocomial pathogens and Mycobacterium tuberculosis isolated from healthcare facilities in the Western Cape: an in-vitro study
- Author
-
Mehtar, S., primary, Wiid, I., additional, and Todorov, S.D., additional
- Published
- 2008
- Full Text
- View/download PDF
13. Boza, a natural source of probiotic lactic acid bacteria
- Author
-
Todorov, S.D., primary, Botes, M., additional, Guigas, C., additional, Schillinger, U., additional, Wiid, I., additional, Wachsman, M.B., additional, Holzapfel, W.H., additional, and Dicks, L.M.T., additional
- Published
- 2007
- Full Text
- View/download PDF
14. O6-alkylguanine-DNA alkyltransferase DNA repair in mycobacteria: pathogenic and non-pathogenic species differ
- Author
-
Wiid, I., primary, Grundlingh, R., additional, Bourn, W., additional, Bradley, G., additional, Harington, A., additional, Hoal-van Helden, E.G., additional, and van Helden, P., additional
- Published
- 2002
- Full Text
- View/download PDF
15. Oligonucleotide (GTG)5 as an epidemiological tool in the study of nontuberculous mycobacteria
- Author
-
Cilliers, F J, primary, Warren, R M, additional, Hauman, J H, additional, Wiid, I J, additional, and van Helden, P D, additional
- Published
- 1997
- Full Text
- View/download PDF
16. Oligonucleotide (GTG)5 as a marker for Mycobacterium tuberculosis strain identification
- Author
-
Wiid, I J, primary, Werely, C, additional, Beyers, N, additional, Donald, P, additional, and van Helden, P D, additional
- Published
- 1994
- Full Text
- View/download PDF
17. Blot hybridisation analysis of genomic DNA.
- Author
-
Vandenplas, S, Wiid, I, Grobler-Rabie, A, Brebner, K, Ricketts, M, Wållis, G, Bester, A, Boyd, C, and Måthew, C
- Abstract
Restriction endonuclease analysis of specific gene sequences is proving to be a valuable technique for characterisation and diagnosis of inherited disorders. This paper describes detailed protocols for isolation, restriction, and blot hybridisation of genomic DNA. Problems and alternatives in the procedure are discussed and a troubleshooting guide has been provided to help rectify faults. [ABSTRACT FROM PUBLISHER]
- Published
- 1984
18. Glutamate dehydrogenase and glutamine synthetase are regulated in response to nitrogen availability in Myocbacterium smegmatis
- Author
-
van Helden Paul, Wiid Ian, Kidd Martin, Hayward Don, and Harper Catriona J
- Subjects
Microbiology ,QR1-502 - Abstract
Abstract Background The assimilation of nitrogen is an essential process in all prokaryotes, yet a relatively limited amount of information is available on nitrogen metabolism in the mycobacteria. The physiological role and pathogenic properties of glutamine synthetase (GS) have been extensively investigated in Mycobacterium tuberculosis. However, little is known about this enzyme in other mycobacterial species, or the role of an additional nitrogen assimilatory pathway via glutamate dehydrogenase (GDH), in the mycobacteria as a whole. We investigated specific enzyme activity and transcription of GS and as well as both possible isoforms of GDH (NAD+- and NADP+-specific GDH) under varying conditions of nitrogen availability in Mycobacterium smegmatis as a model for the mycobacteria. Results It was found that the specific activity of the aminating NADP+-GDH reaction and the deaminating NAD+-GDH reaction did not change appreciably in response to nitrogen availability. However, GS activity as well as the deaminating NADP+-GDH and aminating NAD+-GDH reactions were indeed significantly altered in response to exogenous nitrogen concentrations. Transcription of genes encoding for GS and the GDH isoforms were also found to be regulated under our experimental conditions. Conclusions The physiological role and regulation of GS in M. smegmatis was similar to that which has been described for other mycobacteria, however, in our study the regulation of both NADP+- and NAD+-GDH specific activity in M. smegmatis appeared to be different to that of other Actinomycetales. It was found that NAD+-GDH played an important role in nitrogen assimilation rather than glutamate catabolism as was previously thought, and is it's activity appeared to be regulated in response to nitrogen availability. Transcription of the genes encoding for NAD+-GDH enzymes seem to be regulated in M. smegmatis under the conditions tested and may contribute to the changes in enzyme activity observed, however, our results indicate that an additional regulatory mechanism may be involved. NADP+-GDH seemed to be involved in nitrogen assimilation due to a constitutive aminating activity. The deaminating reaction, however was observed to change in response to varying ammonium concentrations which suggests that NADP+-GDH is also regulated in response to nitrogen availability. The regulation of NADP+-GDH activity was not reflected at the level of gene transcription thereby implicating post-transcriptional modification as a regulatory mechanism in response to nitrogen availability.
- Published
- 2010
- Full Text
- View/download PDF
19. Glutamine synthetase sequence evolution in the mycobacteria and their use as molecular markers for Actinobacteria speciation
- Author
-
Wiid Ian JF, van Helden Paul D, and Hayward Don
- Subjects
Evolution ,QH359-425 - Abstract
Abstract Background Although the gene encoding for glutamine synthetase (glnA) is essential in several organisms, multiple glnA copies have been identified in bacterial genomes such as those of the phylum Actinobacteria, notably the mycobacterial species. Intriguingly, previous reports have shown that only one copy (glnA1) is essential for growth in M. tuberculosis, while the other copies (glnA2, glnA3 and glnA4) are not. Results In this report it is shown that the glnA1 and glnA2 encoded glutamine synthetase sequences were inherited from an Actinobacteria ancestor, while the glnA4 and glnA3 encoded GS sequences were sequentially acquired during Actinobacteria speciation. The glutamine synthetase sequences encoded by glnA4 and glnA3 are undergoing reductive evolution in the mycobacteria, whilst those encoded by glnA1 and glnA2 are more conserved. Conclusion Different selective pressures by the ecological niche that the organisms occupy may influence the sequence evolution of glnA1 and glnA2 and thereby affecting phylogenies based on the protein sequences they encode. The findings in this report may impact the use of similar sequences as molecular markers, as well as shed some light on the evolution of glutamine synthetase in the mycobacteria.
- Published
- 2009
- Full Text
- View/download PDF
20. Anti-Mycobacterial Peroxides: A New Class of Agents for Development Against Tuberculosis.
- Author
-
van der Westhuyzen CW, Haynes RK, Panayides JL, Wiid I, and Parkinson CJ
- Subjects
- Animals, Antitubercular Agents chemical synthesis, Artemisinins chemical synthesis, HeLa Cells, Humans, Microbial Sensitivity Tests, Mycobacterium tuberculosis drug effects, Rats, Tetraoxanes chemical synthesis, Antitubercular Agents pharmacology, Artemisinins pharmacology, Tetraoxanes pharmacology
- Abstract
Background: With few exceptions, existing tuberculosis drugs were developed many years ago and resistance profiles have emerged. This has created a need for new drugs with discrete modes of action. There is evidence that tuberculosis (like other bacteria) is susceptible to oxidative pressure and this has yet to be properly utilised as a therapeutic approach in a manner similar to that which has proven highly successful in malaria therapy., Objective: To develop an alternative approach to the incorporation of bacterial siderophores that results in the creation of antitubercular peroxidic leads for subsequent development as novel agents against tuberculosis., Methods: Eight novel peroxides were prepared and the antitubercular activity (H37Rv) was compared to existing artemisinin derivatives in vitro. The potential for toxicity was evaluated against the L6 rat skeletal myoblast and HeLa cervical cancer lines in vitro., Results: The addition of a pyrimidinyl residue to an artemisinin or, preferably, a tetraoxane peroxidic structure results in antitubercular activity in vitro. The same effect is not observed in the absence of the pyrimidine or with other heteroaromatic substituents., Conclusion: The incorporation of a pyrimidinyl residue adjacent to the peroxidic function in an organic peroxide results in anti-tubercular activity in an otherwise inactive peroxidic compound. This will be a useful approach for creating oxidative drugs to target tuberculosis., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2020
- Full Text
- View/download PDF
21. The role of low molecular weight thiols in Mycobacterium tuberculosis.
- Author
-
Sao Emani C, Gallant JL, Wiid IJ, and Baker B
- Subjects
- Animals, Antitubercular Agents therapeutic use, Cysteine metabolism, Dipeptides metabolism, Enzyme Inhibitors therapeutic use, Enzymes metabolism, Ergothioneine metabolism, Glycopeptides metabolism, Humans, Inositol metabolism, Molecular Targeted Therapy, Molecular Weight, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis pathogenicity, Tuberculosis drug therapy, Mycobacterium tuberculosis metabolism, Sulfhydryl Compounds metabolism, Tuberculosis microbiology
- Abstract
Low molecular weight (LMW) thiols are molecules with a functional sulfhydryl group that enable them to detoxify reactive oxygen species, reactive nitrogen species and other free radicals. Their roles range from their ability to modulate the immune system to their ability to prevent damage of biological molecules such as DNA and proteins by protecting against oxidative, nitrosative and acidic stress. LMW thiols are synthesized and found in both eukaryotes and prokaryotes. Due to their beneficial role to both eukaryotes and prokaryotes, their specific functions need to be elucidated, most especially in pathogenic prokaryotes such as Mycobacterium tuberculosis (M.tb), in order to provide a rationale for targeting their biosynthesis for drug development. Ergothioneine (ERG), mycothiol (MSH) and gamma-glutamylcysteine (GGC) are LMW thiols that have been shown to interplay to protect M.tb against cellular stress. Though ERG, MSH and GGC seem to have overlapping functions, studies are gradually revealing their unique physiological roles. Understanding their unique physiological role during the course of tuberculosis (TB) infection, would pave the way for the development of drugs that target their biosynthetic pathway. This review identifies the knowledge gap in the unique physiological roles of LMW thiols and proposes their mechanistic roles based on previous studies. In addition, it gives an update on identified inhibitors of their biosynthetic enzymes., (Copyright © 2019. Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
22. The evaluation of the anti-cancer drug elesclomol that forms a redox-active copper chelate as a potential anti-tubercular drug.
- Author
-
Ngwane AH, Petersen RD, Baker B, Wiid I, Wong HN, and Haynes RK
- Subjects
- Copper metabolism, Drug Repositioning, Drug Resistance, Multiple, Bacterial drug effects, Humans, Microbial Sensitivity Tests, Oxidation-Reduction, Tuberculosis microbiology, Antineoplastic Agents pharmacology, Antitubercular Agents pharmacology, Chelating Agents pharmacology, Copper chemistry, Hydrazines pharmacology, Mycobacterium tuberculosis drug effects, Tuberculosis drug therapy
- Abstract
The observations that the innate immune system employs copper to eliminate bacterial infection and that resistance to copper enhances virulence of Mycobacterium tuberculosis (Mtb) prompted us to examine the effects the anti-cancer agent elesclomol on Mtb. As a bis-thionohydrazide, elesclomol chelates with copper to form a copper complex in situ that via redox cycling of the metal ion greatly enhances oxidative stress in tumour cells. Here, we demonstrate that elesclomol is relatively potent against Mtb H37Rv with minimum inhibitory concentration of 10 μM (4 mg/L) and against multidrug resistant clinical isolates of Mtb, displays additive interactions with known tuberculosis drugs such as isoniazid and ethambutol, and a synergistic interaction with rifampicin. Controlled supplementation of elesclomol with copper in culture medium increased Mtb sensitivity by >65 fold. Overall, the activities of elesclomol in principle indicate the possibility of repurposing elesclomol or designing new thionohydrazides as potential drugs for use against Mtb. © 2019 IUBMB Life, 71(5):532-538, 2019., (© 2019 International Union of Biochemistry and Molecular Biology.)
- Published
- 2019
- Full Text
- View/download PDF
23. OAS1, 2, and 3: Significance During Active Tuberculosis?
- Author
-
Leisching G, Wiid I, and Baker B
- Subjects
- Animals, Apoptosis physiology, Humans, Interferon Type I metabolism, Signal Transduction physiology, 2',5'-Oligoadenylate Synthetase metabolism, Tuberculosis metabolism
- Abstract
Evidence to-date points to a detrimental role of the type I IFNs during tuberculosis. The mechanisms underpinning the IFNαβ-mediated exacerbation of the disease is unclear. The 2'-5'-oligoadenylate synthetases (OAS), namely OAS1, OAS2 and OAS3 are part of the interferon-induced genes which until now have been synonymous with an anti-viral function. Blood transcriptome profiling has continuously observed their upregulation in a number of gene expression signatures which discriminate active TB from latent TB infection, however the role of the OASs and the effect that their expression has on the pathogenesis and persistence of TB is unknown. Evidence suggests that the OASs exhibit other cellular functions which include the induction of apoptosis, enhancement of IFNαβ signalling, immune cell receptor modulation and autophagy. We propose that i) during the late stages of disease, sustained RNaseL expression through OAS activation enhances type I IFN signalling and, ii) that they may exhibit immune-modulatory capabilities.
- Published
- 2018
- Full Text
- View/download PDF
24. Reversed isoniazids: Design, synthesis and evaluation against Mycobacterium tuberculosis.
- Author
-
Kumar M, Singh K, Ngwane AH, Hamzabegovic F, Abate G, Baker B, Wiid I, Hoft DF, Ruminski P, and Chibale K
- Subjects
- Animals, Antitubercular Agents chemistry, Antitubercular Agents pharmacology, Bacterial Proteins antagonists & inhibitors, Bacterial Proteins metabolism, CHO Cells, Cell Line, Cell Survival drug effects, Cricetinae, Cricetulus, Humans, Ion Pumps antagonists & inhibitors, Ion Pumps metabolism, Isoniazid chemical synthesis, Isoniazid pharmacology, Microbial Sensitivity Tests, Mycobacterium tuberculosis drug effects, Structure-Activity Relationship, Antitubercular Agents chemical synthesis, Drug Design, Isoniazid chemistry
- Abstract
Novel reversed isoniazid (RINH) agents were synthesized by covalently linking isoniazid with various efflux pump inhibitor (EPI) cores and their structural motifs. These RINH agents were then evaluated for anti-mycobacterial activity against sensitive, isoniazid mono-resistant and MDR clinical isolates of M. tuberculosis and a selected number of compounds were also tested ex vivo for intracellular activity as well as in the ethidium bromide (EB) assay for efflux pump inhibition efficacy. The potency of some compounds against various strains of M. tuberculosis (4a-c, 7 and 8; H37Rv-MIC
99 ≤1.25 µM, R5401-MIC99 ≤2.5 µM, X_61-MIC99 ≤5 µM) demonstrated the potential of the reversed anti-TB agent strategy towards the development of novel anti-mycobacterial agents to address the rapidly growing issue of resistance. Further, macrophage activity with >90% inhibition by 1a-c and 3b (MIC90 ≤13.42 µM) and inhibition of EB efflux demonstrated by these compounds are encouraging., (Copyright © 2017 Elsevier Ltd. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
25. Preliminary Evaluation of Artemisinin-Cholesterol Conjugates as Potential Drugs for the Treatment of Intractable Forms of Malaria and Tuberculosis.
- Author
-
Morake M, Coertzen D, Ngwane A, Wentzel JF, Wong HN, Smit FJ, Birkholtz LM, Pietersen RD, Baker B, Wiid I, N'Da DD, and Haynes RK
- Subjects
- Antimalarials pharmacology, Antimalarials therapeutic use, Antitubercular Agents pharmacology, Antitubercular Agents therapeutic use, Cell Survival drug effects, HEK293 Cells, Humans, Malaria drug therapy, Malaria pathology, Mycobacterium tuberculosis drug effects, Plasmodium falciparum drug effects, Structure-Activity Relationship, Tuberculosis drug therapy, Tuberculosis pathology, Antimalarials chemical synthesis, Antitubercular Agents chemical synthesis, Artemisinins chemistry, Cholesterol chemistry
- Abstract
To evaluate the feasibility of developing drugs that may be active against both malaria and tuberculosis (TB) by using in part putative cholesterol transporters in the causative pathogens and through enhancement of passive diffusion in granulomatous TB, artemisinin-cholesterol conjugates were synthesized by connecting the component molecules through various linkers. The compounds were screened in vitro against Plasmodium falciparum (Pf) and Mycobacterium tuberculosis (Mtb). Antimalarial activities (IC
50 ) against Pf drug-sensitive NF54, and drug-resistant K1 and W2 strains ranged from 0.03-2.6, 0.03-1.9, and 0.02-1.7 μm. Although the compounds are less active than the precursor artemisinin derivatives, the cholesterol moiety renders the compounds relatively insoluble in the culture medium, and variation in solubilities among the different compounds may reflect in the range of efficacies observed. Activities against Mtb H37Rv were assessed using a standardized colony-forming unit (CFU) assay after 24 h pretreatment of cultures with each of the compounds. Percentage inhibition ranged from 3-38 % and 18-52 % at 10 and 80 μm, respectively. Thus, in contrast to the comparator drug artemether, the conjugates display enhanced activities. The immediate aims include the preparation of conjugates with enhanced aqueous solubilities, assays against malaria and TB in vivo, and for TB, assays using an infected macrophage model and assessment of granuloma influx., (© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)- Published
- 2018
- Full Text
- View/download PDF
26. Gamma-glutamylcysteine protects ergothioneine-deficient Mycobacterium tuberculosis mutants against oxidative and nitrosative stress.
- Author
-
Sao Emani C, Williams MJ, Van Helden PD, Taylor MJC, Wiid IJ, and Baker B
- Subjects
- Biosynthetic Pathways, Cysteine genetics, Cysteine metabolism, Dipeptides genetics, Ergothioneine metabolism, Gene Deletion, Glycopeptides genetics, Glycopeptides metabolism, Humans, Inositol genetics, Inositol metabolism, Tuberculosis microbiology, Dipeptides metabolism, Ergothioneine genetics, Mycobacterium tuberculosis genetics, Mycobacterium tuberculosis metabolism, Nitrosative Stress, Oxidative Stress
- Abstract
Mycobacterium tuberculosis (M.tb.), the causative agent of tuberculosis (TB), cannot synthesize GSH, but synthesizes two major low molecular weight thiols namely mycothiol (MSH) and ergothioneine (ERG). Gamma-glutamylcysteine (GGC), an intermediate in GSH synthesis, has been implicated in the protection of lactic acid bacteria from oxidative stress in the absence of GSH. In mycobacteria, GGC is an intermediate in ERG biosynthesis, and its formation is catalysed by EgtA (GshA). GGC is subsequently used by EgtB in the formation of hercynine-sulphoxide-GGC. In this study, M.tb. mutants harbouring unmarked, in-frame deletions in each of the fives genes involved in ERG biosynthesis (egtA, egtB, egtC, egtD and egtE) or a marked deletion of the mshA gene (required for MSH biosynthesis) were generated. Liquid chromatography tandem mass spectrometry analyses (LC-MS) revealed that the production of GGC was elevated in the MSH-deficient and the ERG-deficient mutants. The ERG-deficient ΔegtB mutant which accumulated GGC was more resistant to oxidative and nitrosative stress than the ERG-deficient, GGC-deficient ΔegtA mutant. This implicates GGC in the detoxification of reactive oxygen and nitrogen species in M.tb., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
27. Anti-mycobacterium tuberculosis activity of polyherbal medicines used for the treatment of tuberculosis in Eastern Cape, South Africa.
- Author
-
Famewo EB, Clarke AM, Wiid I, Ngwane A, van Helden P, and Afolayan AJ
- Subjects
- Humans, Microbial Sensitivity Tests, Mycobacterium tuberculosis drug effects, South Africa, Antitubercular Agents therapeutic use, Drug Contamination, Isoniazid therapeutic use, Phytotherapy, Plant Extracts therapeutic use, Plants, Medicinal microbiology, Tuberculosis drug therapy
- Abstract
Background: The emergence of drug-resistant strains of Mycobacterium tuberculosis has become a global public health problem. Polyherbal medicines offer great hope for developing alternative drugs for the treatment of tuberculosis., Objective: To evaluate the anti-tubercular activity of polyherbal medicines used for the treatment of tuberculosis., Methods: The remedies were screened against Mycobacterium tuberculosis H37Rv using Middlebrook 7H9 media and MGIT BACTEC 960 system. They were liquid preparations from King Williams Town site A (KWTa), King Williams Town site B (KWTb), King Williams Town site C (KWTc), Hogsback first site (HBfs), Hogsback second site (HBss), Hogsback third site (HBts), East London (EL), Alice (AL) and Fort Beaufort (FB)., Results: The susceptibility testing revealed that all the remedies contain anti-tubercular activity with KWTa, KWTb, KWTc, HBfs, HBts, AL and FB exhibiting more activity at a concentration below 25 µl/ml. Furthermore, MIC values exhibited inhibitory activity with the most active remedies from KWTa, HBfs and HBts at 1.562 µg/ml. However, isoniazid showed more inhibitory activity against M. tuberculosis at 0.05 µg/ml when compare to the polyherbal remedies., Conclusion: This study has indicated that these remedies could be potential sources of new anti-mycobacterial agents against M. tuberculosis . However, the activity of these preparations and their active principles still require in vivo study in order to assess their future as new anti-tuberculosis agents.
- Published
- 2017
- Full Text
- View/download PDF
28. RNAseq reveals hypervirulence-specific host responses to M. tuberculosis infection.
- Author
-
Leisching G, Pietersen RD, van Heerden C, van Helden P, Wiid I, and Baker B
- Subjects
- Animals, Blotting, Western, Cell Cycle Proteins genetics, Gene Expression Profiling, High-Throughput Nucleotide Sequencing, Humans, Interferon Regulatory Factor-3 genetics, Interferon Regulatory Factor-7 genetics, Macrophages microbiology, Mice, Mycobacterium tuberculosis genetics, Mycobacterium tuberculosis immunology, Nuclear Proteins genetics, Real-Time Polymerase Chain Reaction, Signal Transduction, Virulence, Host-Pathogen Interactions, Mycobacterium tuberculosis pathogenicity, Tuberculosis microbiology
- Abstract
The distinguishing factors that characterize the host response to infection with virulent Mycobacterium tuberculosis (M.tb) are largely confounding. We present an infection study with 2 genetically closely related M.tb strains that have vastly different pathogenic characteristics. The early host response to infection with these detergent-free cultured strains was analyzed through RNAseq in an attempt to provide information on the subtleties which may ultimately contribute to the virulent phenotype. Murine bone marrow derived macrophages (BMDMs) were infected with either a hyper- (R5527) or hypovirulent (R1507) Beijing M. tuberculosis clinical isolate. RNAseq revealed 69 differentially expressed host genes in BMDMs during comparison of these 2 transcriptomes. Pathway analysis revealed activation of the stress-induced and growth inhibitory Gadd45 signaling pathway in hypervirulent infected BMDMs. Upstream regulators of interferon activation such as and IRF3 and IRF7 were predicted to be upregulated in hypovirulent-infected BMDMs. Additional analysis of the host immune response through ELISA and qPCR included the use of human THP-1 macrophages where a robust proinflammatory response was observed after infection with the hypervirulent strain. RNAseq revealed 2 early-response genes (ier3 and saa3) and 2 host-defense genes (oasl1 and slpi) that were significantly upregulated by the hypervirulent strain. The role of these genes under M.tb infection conditions are largely unknown but here we provide validation of their presence with use of qPCR and Western blot. Further analysis into their biological role during infection with virulent M.tb is required.
- Published
- 2017
- Full Text
- View/download PDF
29. The Association of OASL and Type I Interferons in the Pathogenesis and Survival of Intracellular Replicating Bacterial Species.
- Author
-
Leisching G, Wiid I, and Baker B
- Subjects
- 2',5'-Oligoadenylate Synthetase classification, 2',5'-Oligoadenylate Synthetase genetics, 2',5'-Oligoadenylate Synthetase physiology, Autophagy physiology, Bacteria growth & development, Bacteria pathogenicity, Cytoplasm genetics, Cytoplasm microbiology, Cytosol immunology, Cytosol microbiology, Gene Expression Regulation immunology, Host-Pathogen Interactions genetics, Humans, Immunity, Innate, Interferon Type I genetics, Mycobacterium immunology, Mycobacterium pathogenicity, Nucleotidyltransferases genetics, Nucleotidyltransferases immunology, Signal Transduction immunology, Vacuoles microbiology, Virus Diseases immunology, 2',5'-Oligoadenylate Synthetase immunology, Bacteria immunology, Cytoplasm immunology, Host-Pathogen Interactions immunology, Interferon Type I immunology
- Abstract
The type I IFN response quickly became associated with its role in the innate immune response to viral infection. The past few years have seen the significance of IFNs expand in breadth to include non-viral pathogens. Previous work has identified that following viral infection, type I IFN signaling induces the production of the 2'-5'-oligoadenylate synthetase (OAS) family, which include OAS1, OAS2, OAS3, and OAS-like (OASL) protein. OASL was identified to be strongly induced following viral infection through engaging the RNA sensor RIG-I and increasing signaling through this pathway to enhance the anti-viral type I IFN response. Surprisingly, infection with viral dsDNA revealed an IFN inhibitory role and therefore pro-viral function of OASL through the inhibition of the cGAS cytosolic DNA sensing mechanism. Intracellular bacteria are able to activate the cytosolic DNA sensing pathway, however the role of OASL during bacterial infection is largely unknown. Vacuolar pathogenic microbes such as mycobacteria induce OASL early post infection, where it functions in a prosurvival fashion by inhibiting autophagic mechanisms and antimicrobial peptide expression. This suggests an underestimated role of OASL in the innate immune response to infection with a variety of pathogens and points to OASL-associated modulation of the type I IFN response. OASL may therefore play a critical role in defining the outcome of infection. We provide a brief update on the recent developments of the OAS family of proteins in response to DNA and RNA virus infections, as well as discuss evidence of Oasl expression in response to a number of cytosolic and vacuolar replicating bacterial pathogens.
- Published
- 2017
- Full Text
- View/download PDF
30. Design, synthesis, and In vitro antituberculosis activity of 2(5H)-Furanone derivatives.
- Author
-
Ngwane AH, Panayides JL, Chouteau F, Macingwana L, Viljoen A, Baker B, Madikane E, de Kock C, Wiesner L, Chibale K, Parkinson CJ, Mmutlane EM, van Helden P, and Wiid I
- Subjects
- Animals, Antitubercular Agents chemical synthesis, Antitubercular Agents chemistry, CHO Cells drug effects, CHO Cells microbiology, Cricetulus, Drug Synergism, Ethambutol administration & dosage, Furans chemical synthesis, Furans chemistry, Humans, Isoniazid administration & dosage, Microbial Sensitivity Tests, Mycobacterium tuberculosis pathogenicity, Rifampin administration & dosage, Tuberculosis microbiology, Antitubercular Agents administration & dosage, Furans administration & dosage, Mycobacterium tuberculosis drug effects, Tuberculosis drug therapy
- Abstract
A series of 2(5H)-furanone-based compounds were synthesized from commercially available mucohalic acids. From the first-generation compounds, three showed inhibitory activity (10 µg/mL) of at least 35% against Mycobacterium smegmatis mc(2) 155 growth (Bioscreen C system). In screening the active first-generation compounds for growth inhibition against Mycobacterium tuberculosis H37Rv, the most active compound was identified with a minimum inhibitory concentration (MIC99 ) of 8.07 µg/mL (15.8 µM) using BACTEC 460 system. No cross-resistance was observed with some current first-line anti-TB drugs, since it similarly inhibited the growth of multidrug resistant (MDR) clinical isolates. The compound showed a good selectivity for mycobacteria since it did not inhibit the growth of selected Gram-positive and Gram-negative bacteria. It also showed synergistic activity with rifampicin (RIF) and additive activity with isoniazid (INH) and ethambutol (EMB). Additional time-kill studies showed that the compound is bacteriostatic to mycobacteria, but cytotoxic to the Chinese Hamster Ovarian (CHO) cell line. From a second generation library, two compounds showed improved anti-TB activity against M. tuberculosis H37Rv and decreased CHO cell cytotoxicity. The compounds exhibited MIC values of 2.62 µg/mL (5.6 µM) and 3.07 µg/mL (5.6 µM) respectively. The improved cytotoxicity against CHO cell line of the two compounds ranged from IC50 = 38.24 µg/mL to IC50 = 45.58 µg/mL when compared to the most active first-generation compound (IC50 = 1.82 µg/mL). The two second generation leads with selectivity indices (SI) of 14.64 and 14.85 respectively, warrant further development as anti-TB drug candidates. © 2016 IUBMB Life, 68(8):612-620, 2016., (© 2016 International Union of Biochemistry and Molecular Biology.)
- Published
- 2016
- Full Text
- View/download PDF
31. The Host Response to a Clinical MDR Mycobacterial Strain Cultured in a Detergent-Free Environment: A Global Transcriptomics Approach.
- Author
-
Leisching G, Pietersen RD, Mpongoshe V, van Heerden C, van Helden P, Wiid I, and Baker B
- Subjects
- Animals, Cells, Cultured, Culture Media chemistry, Culture Media pharmacology, Disease Models, Animal, Drug Resistance, Multiple, Bacterial drug effects, Gene Expression Regulation drug effects, Immunity, Innate drug effects, Macrophages immunology, Macrophages microbiology, Mice, Sequence Analysis, RNA methods, Tuberculosis immunology, Tuberculosis microbiology, Detergents pharmacology, Gene Expression Profiling methods, Polysorbates pharmacology, Tuberculosis genetics
- Abstract
During Mycobacterium tuberculosis (M.tb) infection, the initial interactions between the pathogen and the host cell determines internalization and innate immune response events. It is established that detergents such as Tween alter the mycobacterial cell wall and solubilize various lipids and proteins. The implication of this is significant since induced changes on the cell wall affect macrophage uptake and the immune response to M.tb. Importantly, during transmission between hosts, aerosolized M.tb enters the host in its native form, i.e. in a detergent-free environment, thus in vitro and in vivo studies should mimic this as closely as possible. To this end, we have optimized a procedure for growing and processing detergent-free M.tb and assessed the response of murine macrophages (BMDM) infected with multi drug-resistant M.tb (R179 Beijing 220 clinical isolate) using RNAseq. We compared the effects of the host response to M.tb cultured under standard laboratory conditions (Tween 80 containing medium -R179T), or in detergent-free medium (R179NT). RNAseq comparisons reveal 2651 differentially expressed genes in BMDMs infected with R179T M.tb vs. BMDMs infected with R179NT M.tb. A range of differentially expressed genes involved in BMDM receptor interaction with M.tb (Mrc1, Ifngr1, Tlr9, Fpr1 and Itgax) and pro-inflammatory cytokines/chemokines (Il6, Il1b, Tnf, Ccl5 and Cxcl14) were selected for analysis through qPCR. BMDMs infected with R179NT stimulate a robust inflammatory response. Interestingly, R179NT M.tb induce transcription of Fpr1, a receptor which detects bacterial formyl peptides and initiates a myriad of immune responses. Additionally we show that the host components Cxcl14, with an unknown role in M.tb infection, and Tlr9, an emerging role player, are only stimulated by infection with R179NT M.tb. Taken together, our results suggest that the host response differs significantly in response to Tween 80 cultured M.tb and should therefore not be used in infection experiments.
- Published
- 2016
- Full Text
- View/download PDF
32. Effect of milk fermentation by kefir grains and selected single strains of lactic acid bacteria on the survival of Mycobacterium bovis BCG.
- Author
-
Macuamule CL, Wiid IJ, van Helden PD, Tanner M, and Witthuhn RC
- Subjects
- Africa, Animals, Antibiosis, Cattle, Humans, Lactic Acid metabolism, Cultured Milk Products microbiology, Fermentation physiology, Food Contamination, Lactobacillaceae metabolism, Mycobacterium bovis growth & development
- Abstract
Mycobacterium bovis that causes Bovine tuberculosis (BTB) can be transmitted to humans thought consumption of raw and raw fermented milk products from diseased animals. Lactic acid bacteria (LAB) used in popular traditional milk products in Africa produce anti-microbial compounds that inhibit some pathogenic and spoilage bacteria. M. bovis BCG is an attenuated non-pathogenic vaccine strain of M. bovis and the aim of the study was to determine the effect of the fermentation process on the survival of M. bovis BCG in milk. M. bovis BCG at concentrations of 6 log CFU/ml was added to products of kefir fermentation. The survival of M. bovis BCG was monitored at 12-h intervals for 72 h by enumerating viable cells on Middlebrook 7H10 agar plates enriched with 2% BD BACTEC PANTA™. M. bovis BCG was increasingly reduced in sterile kefir that was fermented for a period of 24h and longer. In the milk fermented with kefir grains, Lactobacillus paracasei subsp. paracasei or Lactobacillus casei, the viability of M. bovis BCG was reduced by 0.4 logs after 24h and by 2 logs after 48 h of fermentation. No viable M. bovis BCG was detected after 60 h of fermentation. Results from this study show that long term fermentation under certain conditions may have the potential to inactivate M. bovis BCG present in the milk. However, to ensure safety of fermented milk in Africa, fermentation should be combined with other hurdle technologies such as boiling and milk pasteurisation., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
33. Synthesis, antimycobacterial evaluation and pharmacophore modeling of analogues of the natural product formononetin.
- Author
-
Mutai P, Pavadai E, Wiid I, Ngwane A, Baker B, and Chibale K
- Subjects
- Antitubercular Agents chemistry, Antitubercular Agents pharmacology, Biological Products chemistry, Biological Products pharmacology, Drug Design, Isoflavones pharmacology, Microbial Sensitivity Tests, Mycobacterium tuberculosis drug effects, Structure-Activity Relationship, Antitubercular Agents chemical synthesis, Biological Products chemical synthesis, Isoflavones chemical synthesis, Isoflavones chemistry
- Abstract
The synthesis and antimycobacterial activity of formononetin analogues is hereby reported. Formononetin and its analogue 11E showed 88% and 95% growth inhibition, respectively, against the H37Rv strain of Mycobacterium tuberculosis. Pharmacophore modeling studies indicated that the presence of a hydroxyl group in formononetin and its analogues, is crucial for maintaining activity., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
34. In vitro study of beneficial properties and safety of lactic acid bacteria isolated from Portuguese fermented meat products.
- Author
-
Todorov SD, Franco BD, and Wiid IJ
- Subjects
- Anti-Bacterial Agents, Bacteriocins biosynthesis, Bioreactors, Drug Resistance, Bacterial, Enterococcus faecium drug effects, Fermentation physiology, Food Microbiology, Lactobacillus isolation & purification, Lactobacillus pathogenicity, Lactobacillus plantarum drug effects, Listeria monocytogenes drug effects, Microbial Sensitivity Tests, Mycobacterium tuberculosis drug effects, Portugal, Probiotics adverse effects, beta-Galactosidase metabolism, Bacteriocins pharmacology, Lactobacillus classification, Meat Products microbiology, Mycobacterium tuberculosis growth & development, Probiotics pharmacology
- Abstract
Many lactic acid bacteria produce bacteriocins with a rather broad spectrum of inhibition, which could offer potential applications in food preservation. Bacteriocin production by starter cultures may bring advantage to these strains in competitive interactions with pathogenic bacteria from the food matrix. The objective of this study was to determine the safety of beneficial strains (Lactobacillus plantarum ST202Ch and ST216Ch, Enterococcus faecium ST211Ch, and Lactobacillus sakei ST22Ch, ST153Ch and ST154Ch) previously isolated from fermented meat products and characterised as bacteriocin producers. Auto-aggregation was strain-specific, and values of 28.97, 27.86 and 28.56% were recorded for L. sakei ST22Ch, ST153Ch and ST154Ch, respectively, 16.95 and 14.58% for L. plantarum ST202Ch and ST216Ch, respectively, and 12.77% for E. faecium ST211Ch. Various degrees of co-aggregation between 28.85 and 44.76% for Listeria monocytogenes 211 and 409, and between 23.60 to 34.96% for E. faecium ATCC 19443 were observed. According to the results of the diffusion method, the studied strains demonstrated susceptibility to penicillin G, ampicillin, amoxicillin, amoxicillin/clavulonic acid, imipenem, linezolid, and tetracycline. In addition, the susceptibility of the six strains to various non-antibiotic commercial drugs was examined. Production of β-galactosidase by L. sakei ST22Ch, ST153Ch and ST154Ch, L. plantarum ST202Ch and ST216Ch, and E. faecium ST211Ch was confirmed by employing sterile filter paper discs impregnated with o-nitrophenyl-β-D-galactopyranose. A statistically significant (P<0.001) inhibition of Mycobacterium tuberculosis growth by bacteriocins produced by L. plantarum ST202Ch (38.3%) and ST216Ch (48.6%), L. sakei ST153Ch (16.2%) and ST154Ch (16.1%), and E. faecium ST211Ch (21.7%) was observed. As determined by the polymerase chain reaction, the tested strains showed a low virulence gene profile.
- Published
- 2014
- Full Text
- View/download PDF
35. Novel linear diamine disubstituted polycyclic 'cage' derivatives as potential antimycobacterial candidates.
- Author
-
Onajole OK, Sosibo S, Govender P, Govender T, van Helden PD, Maguire GE, Mlinarić-Majerski K, Wiid I, and Kruger HG
- Subjects
- Microbial Sensitivity Tests, Mycobacterium tuberculosis drug effects, Polycyclic Compounds pharmacology, Antitubercular Agents chemistry, Antitubercular Agents pharmacology, Diamines chemistry, Diamines pharmacology, Polycyclic Compounds chemistry
- Abstract
As a part of an ongoing project to develop highly potent antituberculosis therapeutics, a series novel polycyclic 'cage' tetra-amines were synthesized and screened for in-vitro antituberculosis activities against the H(37) Rv strain of tuberculosis. Three disubstituted polycyclic moieties, namely pentacyclodecane, pentacycloundecane, and tricyclodecane, were used in this study. Compounds 5 and 7 showed similar activity to SQ109 at a MIC of 1 μm while compounds 4, 6 and 8 displayed MIC activity at 1 < MIC<10 μM against H(37) Rv strain of tuberculosis. Compounds 5, 7 and SQ109 were selected for further screening against, multi-drug resistant, (R1097) and extensively drug resistant, (X149) strains of tuberculosis. Compound 5 showed anti-TB activity of a MIC = 1 μM against multi-drug resistant strain (R1097) and <1 μM against extensively drug resistant strain (X149) while compound 7 and SQ109 showed excellent anti-TB activity against both drug-resistant strains at a MIC < 1 μM. This study demonstrates the first reported analysis of pentacyclo[5.3.0.0 ²,⁵.0³,⁹.0⁴,⁸]decane as a potential therapeutic agent., (© 2011 John Wiley & Sons A/S.)
- Published
- 2011
- Full Text
- View/download PDF
36. Glutamate dehydrogenase and glutamine synthetase are regulated in response to nitrogen availability in Myocbacterium smegmatis.
- Author
-
Harper CJ, Hayward D, Kidd M, Wiid I, and van Helden P
- Subjects
- Glutamic Acid metabolism, Metabolic Networks and Pathways, Models, Biological, Mycobacterium smegmatis enzymology, Mycobacterium smegmatis metabolism, NAD metabolism, NADP metabolism, Bacterial Proteins biosynthesis, Gene Expression Regulation, Bacterial, Gene Expression Regulation, Enzymologic, Glutamate Dehydrogenase biosynthesis, Glutamate-Ammonia Ligase biosynthesis, Mycobacterium smegmatis physiology, Nitrogen metabolism
- Abstract
Background: The assimilation of nitrogen is an essential process in all prokaryotes, yet a relatively limited amount of information is available on nitrogen metabolism in the mycobacteria. The physiological role and pathogenic properties of glutamine synthetase (GS) have been extensively investigated in Mycobacterium tuberculosis. However, little is known about this enzyme in other mycobacterial species, or the role of an additional nitrogen assimilatory pathway via glutamate dehydrogenase (GDH), in the mycobacteria as a whole. We investigated specific enzyme activity and transcription of GS and as well as both possible isoforms of GDH (NAD+- and NADP+-specific GDH) under varying conditions of nitrogen availability in Mycobacterium smegmatis as a model for the mycobacteria., Results: It was found that the specific activity of the aminating NADP+-GDH reaction and the deaminating NAD+-GDH reaction did not change appreciably in response to nitrogen availability. However, GS activity as well as the deaminating NADP+-GDH and aminating NAD+-GDH reactions were indeed significantly altered in response to exogenous nitrogen concentrations. Transcription of genes encoding for GS and the GDH isoforms were also found to be regulated under our experimental conditions., Conclusions: The physiological role and regulation of GS in M. smegmatis was similar to that which has been described for other mycobacteria, however, in our study the regulation of both NADP+- and NAD+-GDH specific activity in M. smegmatis appeared to be different to that of other Actinomycetales. It was found that NAD+-GDH played an important role in nitrogen assimilation rather than glutamate catabolism as was previously thought, and is it's activity appeared to be regulated in response to nitrogen availability. Transcription of the genes encoding for NAD+-GDH enzymes seem to be regulated in M. smegmatis under the conditions tested and may contribute to the changes in enzyme activity observed, however, our results indicate that an additional regulatory mechanism may be involved. NADP+-GDH seemed to be involved in nitrogen assimilation due to a constitutive aminating activity. The deaminating reaction, however was observed to change in response to varying ammonium concentrations which suggests that NADP+-GDH is also regulated in response to nitrogen availability. The regulation of NADP+-GDH activity was not reflected at the level of gene transcription thereby implicating post-transcriptional modification as a regulatory mechanism in response to nitrogen availability.
- Published
- 2010
- Full Text
- View/download PDF
37. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
- Author
-
Onajole OK, Govender P, van Helden PD, Kruger HG, Maguire GE, Wiid I, and Govender T
- Subjects
- Adamantane chemical synthesis, Adamantane chemistry, Adamantane pharmacology, Antitubercular Agents chemistry, Dose-Response Relationship, Drug, Ethylenediamines chemical synthesis, Microbial Sensitivity Tests, Molecular Structure, Stereoisomerism, Adamantane analogs & derivatives, Antitubercular Agents chemical synthesis, Antitubercular Agents pharmacology, Ethylenediamines chemistry, Ethylenediamines pharmacology, Mycobacterium tuberculosis drug effects
- Abstract
As part of an ongoing project to develop highly potent anti-tuberculosis therapeutics, six SQ109 derivatives were synthesized and screened in vitro for their anti-tuberculosis activity against the ATCC strain H37Rv and the extensively drug-resistant clinical strain XDR 173. Compound 16 with an extended alkene chain was the most active against both strains of Mycobacterium tuberculosis within a MIC range of 0.5-0.25 microM. Compound 12 and SQ109 were potent within a MIC range of 1-0.5 microM, whilst compound 18 displayed an activity within the MIC range of 0.5-2 microM against both Mycobacterium tuberculosis strains., (Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
38. Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents.
- Author
-
Onajole OK, Govender K, Govender P, van Helden PD, Kruger HG, Maguire GE, Muthusamy K, Pillay M, Wiid I, and Govender T
- Subjects
- Alkanes chemistry, Animals, Antitubercular Agents chemistry, Cattle, Cell Line, Cell Survival, Inhibitory Concentration 50, Microbial Sensitivity Tests, Molecular Structure, Prenylation, Alkanes chemical synthesis, Alkanes pharmacology, Antitubercular Agents chemical synthesis, Antitubercular Agents pharmacology, Mycobacterium tuberculosis drug effects
- Abstract
As part of an ongoing effort to develop highly potent anti-tuberculosis agents, fourteen pentacyclo-undecane (PCU) tetra-amine compounds were synthesized and screened for their in vitro anti-mycobacterial activity against two TB strains, H37Rv and XDR 194 [an extensively drug-resistant strain of tuberculosis]. Using the broth macrodilution method, nitrofuranylamide based compounds (6a and 6b) showed almost similar activities against the H37Rv strain of Mycobacterium tuberculosis when compared with the control drug, ethambutol. N-Geranyl piperazine PCU (8a) and trans-trans farnesyl piperazine PCU (8b) were 3.2 and 3.7 times more potent than commercially available ethambutol. Both isoprenyl PCU tetra-amine derivatives and N-decyl piperazine PCU (9a) were highly active against the XDR 194 strain of tuberculosis with MICs in the range of 0.63-3.02 microM. Cytotoxicities (IC(50)) of isoprenyl based compounds (8a, 8b) and compound 9a were tested on a mammalian cell line [MDBK (Madin Darby bovine kidney epithelium)] with values of 30, 24 and 25 microM respectively.
- Published
- 2009
- Full Text
- View/download PDF
39. Regulation of nitrogen metabolism in Mycobacterium tuberculosis: a comparison with mechanisms in Corynebacterium glutamicum and Streptomyces coelicolor.
- Author
-
Harper C, Hayward D, Wiid I, and van Helden P
- Subjects
- Animals, Bacterial Proteins metabolism, Gene Expression Regulation, Bacterial, Glutamate-Ammonia Ligase metabolism, Humans, Quaternary Ammonium Compounds metabolism, Signal Transduction physiology, Transcription, Genetic, Corynebacterium glutamicum metabolism, Mycobacterium tuberculosis metabolism, Nitrogen metabolism, Streptomyces coelicolor metabolism
- Abstract
The mechanisms governing the regulation of nitrogen metabolism in Corynebacterium glutamicum and Streptomyces coelicolor have been extensively studied. These Actinomycetales are closely related to the Mycobacterium genus and may therefore serve as a models to elucidate the cascade of nitrogen signalling in other mycobacteria. Some factors involved in nitrogen metabolism in Mycobacterium tuberculosis have been described, including glutamine synthetase and its adenylyltransferase, but not much data concerning the other components involved in the signalling cascade is available. In this review a comparative study of factors involved in nitrogen metabolism in C. glutamicum and S. coelicolor is made to identify similarities with M. tuberculosis on both a genomic and proteomic level. This may provide insight into a potential global mechanism of nitrogen control in Mycobacterium tuberculosis.
- Published
- 2008
- Full Text
- View/download PDF
40. Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected children.
- Author
-
Hesseling AC, Schaaf HS, Victor T, Beyers N, Marais BJ, Cotton MF, Wiid I, Gie RP, van Helden P, and Warren RM
- Subjects
- Animals, Antitubercular Agents pharmacology, Antitubercular Agents therapeutic use, BCG Vaccine adverse effects, Cattle, DNA-Directed RNA Polymerases genetics, Humans, Infant, Isoniazid pharmacology, Isoniazid therapeutic use, Mutation, Mycobacterium bovis genetics, Mycobacterium bovis isolation & purification, Rifampin pharmacology, Rifampin therapeutic use, Tuberculosis, Pulmonary diagnosis, Tuberculosis, Pulmonary prevention & control, Drug Resistance, Bacterial, HIV Infections complications, Mycobacterium bovis drug effects, Tuberculosis, Pulmonary drug therapy, Tuberculosis, Pulmonary microbiology
- Abstract
Guidelines for the diagnosis and management of Bacillus Calmette-Guérin (BCG) disease in children are lacking, and there are limited data on drug resistance of Mycobacterium bovis BCG. A 6-month-old HIV-infected infant presented with right axillary adenitis ipsilateral to the site of BCG immunization. M. tuberculosis complex was cultured from axillary lymph nodes and gastric aspirates, and M. bovis BCG was isolated. Susceptibility testing before initiation of therapy demonstrated inherent resistance to isoniazid. The organism acquired rifampin resistance during therapy. This was confirmed by the presence of a mutation in codon 531 (Ser531Tyr) of the rpoB gene. Treatment guidelines for BCG disease with consideration of inherent and possible acquired drug resistance should be established in settings with high rates of vertical HIV transmission and routine BCG vaccination.
- Published
- 2004
- Full Text
- View/download PDF
41. Differential expression of mycothiol pathway genes: are they affected by antituberculosis drugs?
- Author
-
Hayward D, Wiid I, and van Helden P
- Subjects
- Acetylglucosamine metabolism, Animals, Chromosome Mapping, Computational Biology, Cysteine, Glycopeptides, Growth Inhibitors pharmacology, Humans, Inositol metabolism, Oxidoreductases genetics, Oxidoreductases metabolism, Polymorphism, Restriction Fragment Length, RNA, Antisense pharmacology, Acetylglucosamine analogs & derivatives, Antitubercular Agents pharmacology, Disaccharides metabolism, Enzymes drug effects, Inositol analogs & derivatives, Pyrazoles metabolism, Sulfhydryl Compounds metabolism
- Abstract
Mycothiol (MSH) is the major cellular thiol in Mycobacterium tuberculosis (M.tb). We hypothesize that the mycothiol-dependent detoxification pathway may serve an important role during oxygen stress management in M. tuberculosis, derived from normal aerobic metabolism, the macrophage environment and through the action of anti-tubercular antibiotics, such as Isoniazid (INH). Total mRNA and DNA were isolated from M. bovis BCG at different stages of growth in 7H9 mycobacterial medium. Three genes involved in mycothiol metabolism and encoding the enzymes mycothiol S-conjugate amidase (Mca, Rv1082), NADPH dependent mycothiol reductase (mtr, Rv2855), and N-Acetyl-1-D-myo-Inosityl-2-Amino-2-Deoxy-alpha-D-Glucopyranoside Deacetylase (GlcNAc-Ins deacetylase, Rv1170 or mshB) were investigated for genomic rearrangements and expression. The results show that the genomic domains of the genes remain conserved in evolutionary diverse and unrelated M. tuberculosis isolates. The genes encoding enzymes implicated in mycothiol reduction, mtr (Rv2855) and the mycothiol-dependant detoxification of electrophilic agents, Mca (Rv1082), are shown to be actively transcribed during logarithmic M. bovis BCG growth. The gene encoding GlcNAc-Ins deacetylase (the rate limiting mycothiol biosynthesis step) shows induction in the presence of INH. Antisense oligonucleotides to both GlcNAc-Ins deacetylase (Rv1170) and mtr (Rv2855) mRNA affect mycobacterial growth. In conclusion the results presented here suggest that these enzymes are sensitive to free radical generating antituberculosis drugs and may be useful targets for new drug development.
- Published
- 2004
- Full Text
- View/download PDF
42. Potentiation of isoniazid activity against Mycobacterium tuberculosis by melatonin.
- Author
-
Wiid I, Hoal-van Helden E, Hon D, Lombard C, and van Helden P
- Subjects
- Drug Resistance, Multiple, Drug Synergism, Humans, Microbial Sensitivity Tests, Mycobacterium tuberculosis cytology, Antioxidants pharmacology, Antitubercular Agents pharmacology, Isoniazid pharmacology, Melatonin pharmacology, Mycobacterium tuberculosis drug effects
- Abstract
The limited number of effective antituberculosis drugs available necessitates optimizing current treatments. We show that melatonin, which is synthesized in the pineal gland, can cause at least a threefold increase in the efficacy of isoniazid. This suggests that tuberculosis chemotherapy can be improved by innate molecules such as melatonin.
- Published
- 1999
- Full Text
- View/download PDF
43. Detection by DNA fingerprinting of somatic changes during the establishment of a new prostate cell line.
- Author
-
van Helden PD, Wiid IJ, Hoal-van Helden EG, Bey E, and Cohen R
- Subjects
- Aged, DNA analysis, DNA, Neoplasm analysis, Humans, Immunohistochemistry, Leukocytes chemistry, Male, Adenocarcinoma genetics, Adenocarcinoma pathology, DNA Fingerprinting, Prostatic Neoplasms genetics, Prostatic Neoplasms pathology, Tumor Cells, Cultured
- Abstract
The establishment of a new prostate cell line (BM1604) from a human prostatic adenocarcinoma is reported. The line was rapidly established by culture of tissue on an extracellular matrix, previously laid down by culture of non-related cells. The method has been shown to work well, and other prostate lines have recently been cultured in this way. The cells have a doubling time of 28 h. DNA fingerprinting comparison of the genome from the tumour, the germline and the cells shows that somatic mutations have occurred in the tumour and that clonal selection has clearly occurred in establishment of the line. Many somatic mutations are apparent in the selected cells, which are now stable in culture. This method and the cells may be a useful addition to the limited material available for the in vitro study of prostate cells.
- Published
- 1994
- Full Text
- View/download PDF
44. An inexpensive approach to ultracentrifugation of small volume suspensions.
- Author
-
Wiid IJ and Huisamen B
- Subjects
- Biotechnology, Costs and Cost Analysis, Evaluation Studies as Topic, Ultracentrifugation economics, Ultracentrifugation instrumentation
- Published
- 1993
45. Chronic atrophic gastritis, gastric pH, nitrites and micronutrient levels in a population at risk for gastric carcinoma.
- Author
-
Jaskiewicz K, Van Helden PD, Wiid IJ, Steenkamp HJ, and Van Wyk MJ
- Subjects
- Ascorbic Acid analysis, Ascorbic Acid blood, Endoscopy, Female, Gastric Acidity Determination, Gastric Mucosa pathology, Gastritis, Atrophic pathology, Humans, Male, Middle Aged, Risk Factors, Stomach Neoplasms diagnosis, Stomach Neoplasms pathology, Stomach Ulcer pathology, Stomach Ulcer physiopathology, Vitamin A blood, Vitamin E blood, Gastric Juice analysis, Gastritis physiopathology, Gastritis, Atrophic physiopathology, Nitrites analysis, Stomach Neoplasms etiology, Vitamins analysis
- Abstract
One hundred and seventy-eight patients at risk for gastric carcinoma had upper gastrointestinal endoscopy. Twenty-seven selected patients with the type B of chronic atrophic gastritis, 32 patients with normal mucosa and 47 non-scoped healthy controls were tested for plasma vitamin C, retinol and tocopherol. The total vitamin C level was also assessed in gastric juice of scoped patients. Micronutrient levels were related to gastric pH, nitrites and gastric mucosal pathology. The study showed a higher level of pH (greater than 4) and high nitrites in gastric juice in patients with chronic atrophic gastritis, gastric malignant and dysplastic lesions. Neither the hypochlorhydria nor gastric nitrites affected the prevalence of C. pylori in gastric mucosa. Low gastric and plasma concentrations of vitamin C observed in patients with chronic atrophic gastritis showed an inverted relationship with pH level, and an inter-relationship of other vitamins with antioxidant properties (vitamins A and E).
- Published
- 1990
46. Evidence for transcriptional regulation of the myosin heavy chain gene during myogenesis.
- Author
-
Wiid IJ, Boyd CD, Bester AJ, and Van Helden PD
- Subjects
- Animals, Cell Differentiation, Cell Nucleus metabolism, Chick Embryo, Chickens, DNA metabolism, DNA Restriction Enzymes, Muscles metabolism, Nucleic Acid Hybridization, Poly A genetics, RNA genetics, RNA, Messenger, Genes, Muscles embryology, Myosins genetics, Transcription, Genetic
- Abstract
One of the changes accompanying skeletal muscle cell (myoblast) fusion is a dramatic increase in synthesis of muscle specific proteins, one of which is myosin. The underlying mechanism for this burst in synthesis is not yet understood but may occur by two mechanisms: (a) gradual storage of mRNA and translational control as found by others or (b) gene activation and rapid synthesis of mRNA for immediate translation. In this paper we show that the myosin gene changes its organization such that postfusion skeletal muscle cells show an increased susceptibility to DNase I, a recognized probe for gene activation. We also show that this change accompanies an increase in rate of transcription and an increased cell content of myosin heavy chain mRNA. This work shows that transcriptional control is an important mechanism during muscle cell development in addition to the translational control shown by other workers.
- Published
- 1984
- Full Text
- View/download PDF
47. Cross-contamination of human esophageal squamous carcinoma cell lines detected by DNA fingerprint analysis.
- Author
-
van Helden PD, Wiid IJ, Albrecht CF, Theron E, Thornley AL, and Hoal-van Helden EG
- Subjects
- Cell Line, HeLa Cells analysis, Humans, Carcinoma, Squamous Cell genetics, DNA, Neoplasm analysis, Esophageal Neoplasms genetics, Nucleotide Mapping
- Abstract
DNA "fingerprint" analysis has recently become known as a valuable technique for positive identification of any given individual. The chances for mistaken identity have been estimated to be 10(-6) for close siblings or as little as 10(-23) for randomly selected individuals. This methodology thus represents a significant improvement over previously established identification tests using protein or enzyme analysis techniques and has already found application in forensic medicine. One of the chief problems in tissue culture studies is the question of the unequivocal identity of the cultured cells used and the very real possibility of their being contaminated by cells of a similar morphological appearance. We report here the application of the DNA "fingerprint" technique to the genotypic analysis of cultured human squamous carcinoma cells. The results show that a number of lines, designation HCu, have become cross-contaminated. Lines SNO, HCu 10, and HCu 13 are genetically distinct, however lines HCu 10, 18, 33, 37, and 39 are genetically identical and are in fact subcultures of the same cells. In addition, a myocardial line known as Girardi is shown to be identical to HeLa cells. The introduction of this technique to tissue culture laboratories could therefore prevent contaminated cultures from being disseminated or used in research studies.
- Published
- 1988
48. Structural alterations in chromatin during myogenesis in the chicken.
- Author
-
Wiid IJ, Durrheim G, Bester AJ, and van Helden PD
- Subjects
- Animals, Cell Differentiation, Chickens, DNA analysis, Deoxyribonuclease I pharmacology, Electrophoresis, Agar Gel, Micrococcal Nuclease pharmacology, Muscles cytology, Nucleic Acid Denaturation, Nucleosomes, RNA analysis, Transcription, Genetic, Chromatin analysis, Muscle Development, Muscle Proteins biosynthesis
- Abstract
Differentiation of mononucleated myoblasts to multinucleated myotubes is accompanied by hypertrophy achieved by co-ordinated synthesis of muscle proteins. This process may be achieved by co-ordinated synthesis and translation of new mRNA or gradual accumulation of constitutively synthesized mRNA, followed by coordinated translational activation. If the former process occurs, many structural alterations should occur in chromatin, whereas in the latter scenario, no chromatin changes will be necessary. The results of our investigation into chromatin structure of myoblast and myotube nuclei show that according to techniques used, viz. chromatin solubilization by nucleases, thermal denaturation, in vitro transcription, nucleosome sizing, there are major structural changes in chromatin during muscle cell differentiation. Since these alterations were detectable at a fairly gross level, many genes must be affected which could account for the increase in RNA and proteins observed in myotubes. This evidence argus in favour of new mRNA synthesis for rapid translation, rather than a gradual accumulation of mRNA followed by co-ordinated translation.
- Published
- 1988
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.